Skip to main content
Cardiolucent

Service

Advanced Lipid Management and Cholesterol Treatment Strategies (Lipidology)

Assessments & Care Plans

A standard cholesterol panel reports total cholesterol, LDL, HDL, and triglycerides — useful, but incomplete. Advanced lipid management adds particle-based measurements like ApoB, LDL-P, and Lp(a), which more accurately reflect the number of artery-damaging particles in your bloodstream. Dr. Kedan uses this fuller picture to build a targeted strategy that actually moves cardiovascular risk, rather than chasing a single LDL number — and integrates it with the rest of your cardiovascular plan.

What's Included

  • Comprehensive advanced lipid panel including ApoB, LDL-P, and Lp(a)
  • Lipoprotein subfraction analysis when clinically useful
  • hs-CRP and inflammatory marker testing alongside lipid analysis
  • Personalized statin selection and dose optimization
  • Non-statin options — ezetimibe, PCSK9 inhibitors, bempedoic acid — when appropriate
  • Nutrition and lifestyle counseling specifically targeted at lipid biology
  • Structured follow-up testing at 6–12 weeks after any therapy change

How This Helps You

You discover risk that's hidden when standard LDL looks acceptable. ApoB counts the atherogenic particles that actually drive plaque formation; Lp(a) is a largely genetic lipid that independently raises heart attack and stroke risk and is rarely measured by primary care. Together they identify patients who are quietly under-treated, and they let Dr. Kedan choose therapy aimed at the right physiologic target rather than the most convenient number.

Who This Is For

  • Patients with a personal or family history of early heart attack or stroke
  • People with prior coronary events, stents, or bypass
  • Patients with stubbornly abnormal cholesterol despite treatment
  • People with statin intolerance who need an alternative strategy
  • Patients with elevated Lp(a) or known familial hypercholesterolemia
  • Anyone with a borderline lipid profile whose risk is genuinely unclear
  • Patients who want their existing lipid plan reviewed against the latest evidence

What to Expect at Your Visit

The first visit runs 60+ minutes and includes a detailed cardiovascular and lipid history, focused exam, POCUS, and advanced lipid lab orders. A follow-up integrates the results into a written treatment plan with specific ApoB and LDL targets, medication selection, and lifestyle guidance. Most patients repeat advanced lipid testing 6–12 weeks after starting or adjusting therapy, then every 6–12 months once levels are stable. Lp(a) is largely genetic and typically measured once.

Why Cardiolucent

Lipid optimization takes time and iteration — choosing the right drug, titrating to target, monitoring for tolerance, and folding lifestyle change into the same plan. Dr. Kedan personally handles each titration step and is reachable directly between visits, so questions about side effects or new symptoms get same-day answers rather than three-week portal delays. Every lipid decision is integrated with blood pressure, metabolic, and imaging data so the whole plan moves in the same direction.

Common Questions

Frequently Asked Questions

What is advanced lipid management and how is it different from a standard cholesterol test?
A standard cholesterol panel reports total cholesterol, LDL, HDL, and triglycerides — useful, but incomplete. Advanced lipid management adds particle-based measurements like ApoB, LDL-P, and Lp(a), which more accurately reflect the number of artery-damaging particles in your bloodstream. Dr. Kedan uses this fuller picture to tailor treatment that actually moves cardiovascular risk, rather than chasing a single LDL number.
Why do ApoB and Lp(a) matter?
ApoB counts the atherogenic particles that drive plaque formation, and it often reveals risk that's hidden when LDL looks acceptable. Lp(a) is a largely genetic lipid that independently raises heart attack and stroke risk and is rarely measured by primary care. Together they help identify patients who are quietly under-treated despite "normal" cholesterol numbers.
Who should consider an advanced lipid evaluation?
Anyone with a personal or family history of early heart disease, prior coronary events, stubbornly abnormal cholesterol, statin intolerance, or unexplained cardiovascular risk benefits from this workup. It's also valuable for patients who want to be sure their current lipid plan is genuinely optimized rather than acceptable. Schedule a consultation with Dr. Kedan if you fit any of those categories.
Will I need to go on a statin?
Not automatically. Statins are the most evidence-backed lipid-lowering drugs and are often the right choice, but Dr. Kedan also uses non-statin options — ezetimibe, PCSK9 inhibitors, bempedoic acid, and others — when statins aren't tolerated or aren't enough on their own. Medication decisions are anchored in your particle data, overall risk, and personal preferences.
Can lifestyle changes alone fix my cholesterol?
For some patients, yes — meaningful improvement is possible with sustained changes to nutrition, body composition, and exercise. For patients with high genetic risk, elevated Lp(a), or established cardiovascular disease, lifestyle alone usually isn't enough and medication adds substantial benefit. Dr. Kedan builds a plan that uses lifestyle and pharmacology together rather than treating them as alternatives.
How often will I need follow-up testing?
Most patients repeat advanced lipid testing 6–12 weeks after starting or adjusting therapy, then every 6–12 months once levels are stable. Lp(a) is largely genetic and only needs to be measured once in most cases. The cadence is set in your personalized plan and adjusted based on response.
What are the risks or side effects of lipid-lowering medications?
Modern lipid-lowering drugs are generally well-tolerated. Statins can occasionally cause muscle discomfort or transient liver enzyme changes; PCSK9 inhibitors are injections with very few systemic side effects. Dr. Kedan monitors closely after any medication change and will switch strategies if you don't tolerate the first choice well. The goal is the most aggressive treatment you tolerate comfortably.
How does lipid management fit into my overall heart risk plan?
Lipids are one of the most modifiable cardiovascular risk factors, but they don't sit in isolation. Dr. Kedan integrates lipid strategy with blood pressure control, metabolic health, imaging findings, and inflammation markers like hs-CRP so every intervention reinforces the others. You get a single coherent plan rather than parallel treatments that don't talk to each other.
Is advanced lipid testing covered by insurance?
Cardiolucent does not accept Medicare or insurance and bills patients directly, and advanced lipid panels are billed at the lab's rate. We provide a detailed superbill you can submit to your carrier for out-of-network reimbursement; many advanced lipid markers are covered when ordered with appropriate clinical justification. Call (310) 304-5555 with billing questions before scheduling.

Explore

Related Services

Ready to learn more about Advanced Lipid Management and Cholesterol Treatment Strategies (Lipidology)?

Schedule a private consultation with Dr. Kedan in Beverly Hills.
Schedule an Appointment

Medical Disclaimer

The information on this site is for general educational purposes only and is not medical advice, diagnosis, or treatment. Reading this site does not create a doctor–patient relationship. Always consult a qualified healthcare professional for personal guidance. If this is an emergency, call 911. Mentions of medications, devices, or procedures are informational and not endorsements. Full medical disclaimer.

†Some listed indications involve investigational/off-label use. Learn more.